The WACC of Maitri Health Technologies Corp (MTEC.CN) is 8.9%.
Range | Selected | |
Cost of equity | 7.7% - 10.2% | 8.95% |
Tax rate | 26.5% - 26.5% | 26.5% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 7.7% - 10.1% | 8.9% |
Category | Low | High |
Long-term bond rate | 3.4% | 3.9% |
Equity market risk premium | 4.7% | 5.7% |
Adjusted beta | 0.92 | 1.01 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.7% | 10.2% |
Tax rate | 26.5% | 26.5% |
Debt/Equity ratio | 0.01 | 0.01 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 7.7% | 10.1% |
Selected WACC | 8.9% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
MTEC.CN | Maitri Health Technologies Corp | 0.01 | 2.21 | 2.21 |
CRFT.CN | BC Craft Supply Co Ltd | 4.27 | 3.55 | 0.86 |
FWAV | Fourth Wave Energy Inc | 0.15 | 0.91 | 0.82 |
GAIA.CN | Gaia Grow Corp | 5.91 | -1.25 | -0.23 |
INEO.V | INEO Tech Corp | 0.43 | 1.11 | 0.84 |
LLP.CN | LeanLife Health Inc | 0.05 | 0.6 | 0.58 |
PACR.CN | Pac Roots Cannabis Corp | 0.04 | 1.07 | 1.03 |
RMHB | Rocky Mountain High Brands Inc | 0.48 | 0.32 | 0.24 |
TBI.CN | Thoughtful Brands Inc | 0.04 | 0.94 | 0.91 |
VM.V | Voyageur Pharmaceuticals Ltd | 0 | -2.28 | -2.28 |
ZRO.CN | Biosenta Inc | 1.27 | 2.61 | 1.35 |
Low | High | |
Unlevered beta | 0.82 | 0.86 |
Relevered beta | 0.88 | 1.01 |
Adjusted relevered beta | 0.92 | 1.01 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for MTEC.CN:
cost_of_equity (8.95%) = risk_free_rate (3.65%) + equity_risk_premium (5.20%) * adjusted_beta (0.92) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.